Image

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Comparing IV Telisotuzumab Vedotin and Docetaxel for non-squamous lung cancer.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for adults with a type of lung cancer called non-squamous non-small cell lung cancer (NSCLC) who have already received treatment. The goal is to see if a new drug, telisotuzumab vedotin (an experimental drug), works better than docetaxel (a standard chemotherapy drug) and to check its safety. Participants will be randomly divided into two groups. One group will get telisotuzumab vedotin through an intravenous (IV) infusion every 2 weeks, while the other will get docetaxel IV every 3 weeks. About 698 participants from around the world will join.

  • Participating involves regular hospital visits for check-ups, blood tests, and questionnaires.
  • This study may have more side effects compared to usual care.
  • Participants will not receive compensation but will contribute to important cancer research.
Print
Study details
    Non Small Cell Lung Cancer

NCT04928846

AbbVie

22 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.